Company intelligence / Profile preview

EndoCell Therapeutics

Geneva, Geneva, Switzerland
Ownership
Private
Development stage
Other
01

Overview

EndoCell Therapeutics is a Swiss biotechnology company dedicated to developing a functional cure for Type 1 Diabetes through innovative cell therapy. The company's proprietary platform engineers non-pancreatic human cells to become glucose-responsive, insulin-secreting "EndoCells." By bypassing the need for scarce donor islets and potentially reducing the requirement for chronic immunosuppression, EndoCell aims to provide a scalable and effective treatment for insulin-dependent patients. The company is a spin-off from the University of Geneva and is currently advancing its lead program through pre-clinical validation.

Therapeutic areas
Endocrinology
Modalities
Cell therapyGene-edited cell therapy
Industry
Biotech
02

Drug pipeline

1 asset

E-islet 01

2
03

Partnerships

University of GenevaUniversity Hospitals of Geneva

Beyond the preview

Go deeper on EndoCell Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndoCell Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call